BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 2179790)

  • 21. Effects of early initiated oestrogen replacement therapy on plasma homocysteine levels in women in surgically induced menopause.
    Yüksel H; Cobanoğlu M; Odabaşi AR; Sezer SD; Küçük M; Serter M
    Gynecol Endocrinol; 2011 Feb; 27(2):101-6. PubMed ID: 20504097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian failure including menopause, premature menopause, and resistant ovarian syndrome, and hormonal replacement.
    Katz E; McClamrock HD; Adashi EY
    Curr Opin Obstet Gynecol; 1990 Jun; 2(3):392-7. PubMed ID: 2102334
    [No Abstract]   [Full Text] [Related]  

  • 23. Physiologic aspects of natural and surgical menopause.
    Bachmann G
    J Reprod Med; 2001 Mar; 46(3 Suppl):307-15. PubMed ID: 11310451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effects of hormone replacement therapy (HRT) on lipid metabolism in the menopause].
    Camilli A; Di Benedetto L; Camilli FM; Ermini M
    Minerva Ginecol; 1997 May; 49(5):199-202. PubMed ID: 9304079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer.
    Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Aiduk C
    Gynecol Oncol; 1997 Jul; 66(1):103-7. PubMed ID: 9234929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preserving cardiovascular benefits of hormone replacement therapy.
    Bush TL
    J Reprod Med; 2000 Mar; 45(3 Suppl):259-73. PubMed ID: 10756507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contraception for the perimenopausal patient.
    Upton GV
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):207-27. PubMed ID: 3306520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The adverse effects of hormonal therapy.
    Bush TL
    Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures.
    Cagnacci A; Zanin R; Cannoletta M; Generali M; Caretto S; Volpe A
    Fertil Steril; 2007 Dec; 88(6):1603-8. PubMed ID: 17481628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemostatic variables and menopausal status: influence of hormone replacement therapy.
    Scarabin PY; Plu-Bureau G; Bara L; Bonithon-Kopp C; Guize L; Samama MM
    Thromb Haemost; 1993 Oct; 70(4):584-7. PubMed ID: 8115983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate.
    Castelo-Branco C; Casals E; Sanllehy C; Duran M; Fortuny A; Vanrell JA
    J Reprod Med; 1996 Nov; 41(11):833-8. PubMed ID: 8951134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal approaches to breast cancer treatment and prevention: an overview.
    Vogel CL
    Semin Oncol; 1996 Aug; 23(4 Suppl 9):2-9. PubMed ID: 8824459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone replacement therapy and estrogen-dependent cancers.
    Birkhäuser M
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():99-114. PubMed ID: 7874193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration.
    Stefanick ML
    Am J Med; 2005 Dec; 118 Suppl 12B():64-73. PubMed ID: 16414329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy with climara in surgical menopause.
    Bădoi D; Crauciuc E; Rusu L; Luca V
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):828-33. PubMed ID: 23272537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in Lp(a) lipoprotein and lipid levels after cessation of female sex hormone production and estrogen replacement therapy.
    Kim CJ; Ryu WS; Kwak JW; Park CT; Ryoo UH
    Arch Intern Med; 1996 Mar; 156(5):500-4. PubMed ID: 8604955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variations on hormone replacement therapy: an answer to the 'one dose fits all' Women's Health Initiative study.
    Studd J
    Gynecol Endocrinol; 2007 Nov; 23(11):665-71. PubMed ID: 17943531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen-replacement therapy in younger women with breast cancer.
    Theriault RL; Sellin RV
    J Natl Cancer Inst Monogr; 1994; (16):149-52. PubMed ID: 7999457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune effects of surgical menopause and estrogen replacement therapy in peri-menopausal women.
    Kumru S; Godekmerdan A; Yilmaz B
    J Reprod Immunol; 2004 Aug; 63(1):31-8. PubMed ID: 15284002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.